PAHC earnings
Phibro Animal Health Corporation (PAHC) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Diluted earnings per share of $0.67, an increase of $0.59 Adjusted EBITDA of $68.1 million, an increase of $19.9 million, or 41% Adjusted net income of $35.7 million, an increase of $13.5 million, or 60% Adjusted dil
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To
- Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To a
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) Net sales of $378.7 million, an increase of $105.5 million, or 39% Net income of $17.2 million, an increase of $16.5 million Diluted earnings per share of $0.42, an increase of $0.40 Adjusted EBITDA of $50.0 million, an increase of $16.5 million, or 49% Adjusted net income of $23.2 million, an increase of $6.6 million, or 39% Adjusted
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of
- Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnings per share of $0.51, an increase of $0.30 Adjusted EBITDA of $54.9 million, an increase of $25.2 million, or 85% Adjusted net income of $25.7 million, an increase of $13.0 million Adjusted diluted EPS of $0.63, an incr
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the we
- Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended December 31, 2024 (compared to the three months ended December 31, 2023) Net sales of $309.3 million, an increase of $59.3 million, or 24% Net income of $3.2 million, an increase of $1.9 million Diluted earnings per share of $0.08, an increase of $0.05 Adjusted EBITDA of $48.2 million, an increase of $18.7 million, or 64% Adjusted net income of $21.9 million, an increase of $8.5 million, or 63% Adjusted diluted
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To
- Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended September 30, 2024 (compared to the three months ended September 30, 2023) Net sales of $260.4 million, an increase of $29.1 million, or 13% Net income of $7.0 million, an increase of $15.0 million Diluted income per share of $0.17, an increase of $0.37 Adjusted EBITDA of $30.7 million, an increase of $12.0 million, or 64% Adjusted net income of $14.1 million, an increase of $8.6 million Adjusted diluted EPS of $0.35,
- Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 6, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 7, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To acc
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance for the year ending June 30, 2025. Highlights for the three months ended June 30, 2024 (compared to the three months ended June 30, 2023) Net sales of $273.2 million, an increase of $18.1 million, or 7% Net income of $0.8 million, a decrease of $10.7 million Diluted earnings per share of $0.02, a decrease of $0.26 Adjusted EBITDA of $33.4 million, an increase of $1.1 million, or 3% Adjusted net income of $16.7 million, an increase of $1.5 million, or 10% Adjusted diluted
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2024 financial results on Wednesday, August 28, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 29, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of
- Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2024, and its updated financial guidance for the year ending June 30, 2024. Highlights for the three months ended March 31, 2024 (compared to the three months ended March 31, 2023) Net sales of $263.2 million, an increase of $17.6 million, or 7% Net income of $8.4 million, a decrease of $1.6 million Diluted earnings per share of $0.21, a decrease of $0.04 Adjusted EBITDA of $29.7 million, an increase of $2.3 million, or 9% Adjusted net income of $12.7 million, an increase of $1.1 million, or 9% Adjusted diluted EPS of $0.31, a
- Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal HealthZoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis' medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428775498/en/ Both Zoetis and Phibro Animal Health have a longstanding commitment to the production animal health sector. The acquired product portfolio
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 8, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 9, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the
- Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2023 and its updated financial guidance for the year ending June 30, 2024. Highlights for the three months ended December 31, 2023 (compared to the three months ended December 31, 2022) Net sales of $249.9 million, an increase of $5.3 million, or 2% Net income of $1.3 million, a decrease of $5.9 million Diluted earnings per share of $0.03, a decrease of $0.15 Adjusted EBITDA of $29.5 million, a decrease of $1.5 million, or 5% Adjusted net income of $13.5 million, a decrease of $0.3 million, or 2% Adjusted diluted EPS of $0
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 7, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 8, 2024, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To
- Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2023, and its updated financial guidance for the year ending June 30, 2024. Highlights for the three months ended September 30, 2023 (compared to the three months ended September 30, 2022) Net sales of $231.3 million, a decrease of $1.2 million, or 1% Net loss of $8.0 million, a decrease of $11.9 million Diluted loss per share of $0.20, a decrease of $0.30 Adjusted EBITDA of $18.7 million, a decrease of $3.5 million, or 16% Adjusted net income of $5.5 million, a decrease of $2.8 million, or 33% Adjusted diluted EPS of $0.1
- Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 8, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 9, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To a
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2023, and provided guidance for the year ending June 30, 2024. Highlights for the three months ended June 30, 2023 (compared to the three months ended June 30, 2022) Net sales of $255.0 million, a decrease of $0.2 million, or less than 1% Net income of $11.5 million, an increase of $4.0 million, or 54% Diluted EPS of $0.28, an increase of $0.10, or 54% Adjusted EBITDA of $32.3 million, an increase of $0.8 million, or 3% Adjusted net income of $15.2 million, an increase of $0.7 million, or 5% Adjusted diluted EP
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2023 financial results on Wednesday, August 30, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 31, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting http://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884 A replay of the webcast will be available approximately two hours after the conclusion of th
- Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter and year-to-date ended March 31, 2023. Highlights for the three months ended March 31, 2023 (compared to the three months ended March 31, 2022) Net sales of $245.7 million, an increase of $6.1 million, or 3% Net income of $10.0 million, a decrease of $7.6 million, or 43% Diluted EPS of $0.25, a decrease of $0.19, or 43% Adjusted EBITDA of $27.4 million, a decrease of $0.6 million, or 2% Adjusted net income of $11.6 million, a decrease of $1.7 million, or 13% Adjusted diluted EPS of $0.29, a decrease of $0.04, or 13% Highlights for the nine
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 3, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 4, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the
- Phibro Animal Health Corporation Reports Second Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its second quarter ended December 31, 2022. Highlights for the three months ended December 31, 2022 (compared to the three months ended December 31, 2021) Net sales of $244.6 million, an increase of $11.9 million, or 5% Net income of $7.2 million, a decrease of $10.3 million, or 59% Diluted EPS of $0.18, a decrease of $0.25, or 59% Adjusted EBITDA of $30.9 million, an increase of $1.8 million, or 6% Adjusted net income of $13.8 million, a decrease of $1.3 million, or 9% Adjusted diluted EPS of $0.34, a decrease of $0.03, or 9% COMMENTARY "We were pleased with our
- Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 8, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 9, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To ac
- Phibro Animal Health Corporation Reports First Quarter Results, Revised GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjusted EBITDA and revised its guidance for Net income, Diluted EPS, Adjusted net income, Adjusted diluted EPS and Adjusted effective tax rate for the year ending June 30, 2023. Highlights for the three months ended September 30, 2022 (compared to the three months ended September 30, 2021) Net sales of $232.5 million, an increase of $17.9 million, or 8% Net income of $3.9 million, a decrease of $2.7 million, or 41% Diluted EPS of $0.10, a decrease of $0.07, or 41% Adjuste
- Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 10, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To ac
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) ("Phibro" or the "Company") today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial guidance for the year ending June 30, 2023. Highlights for the three months ended June 30, 2022 (compared to the three months ended June 30, 2021) Net sales of $255.3 million, an increase of $35.0 million, or 16% Net income of $7.5 million, a decrease of $9.6 million, or 56% Diluted EPS of $0.18, a decrease of $0.24, or 56% Adjusted EBITDA of $31.5 million, an increase of $4.5 million, or 17% Adjusted Net Income of $14.5 million, an increase of $1.7 million, or 13% Adjusted diluted EPS of
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2022 ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2022 financial results on Wednesday, August 24, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 25, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of th
- Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its third quarter ended March 31, 2022. Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $27.9 million, or 13% Net income of $17.7 million, an increase of $5.5 million, or 45% Diluted EPS of $0.44, an increase of $0.14 or 47% Adjusted EBITDA of $28.0 million, comparable to the prior year Adjusted Net Income of $13.4 million, a decrease of $0.5 million, or 4% Adjusted diluted EPS of $0.33, a decrease of $0.01, or 3% We are raising our fiscal year 2022 net sales projection, while leaving uncha
- Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2022 Quarterly Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Wednesday, May 4, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 5, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the we
- Phibro Animal Health Corporation Reports Second Quarter Results, Provides Revised Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its second quarter ended December 31, 2021. Highlights for the three months ended December 31, 2021 (compared to the three months ended December 31, 2020) Net sales of $233 million, an increase of $27 million, or 13% Net income of $17 million, an increase of $5 million, or 36% Diluted EPS of $0.43, an increase of $0.11 or 34% Adjusted EBITDA of $29 million, an increase of $1 million, or 2% Adjusted Net Income of $15 million, an increase of $1 million, or 9% Adjusted diluted EPS of $0.37, an increase of $0.03, or 9% Our revised projections of financial performance for the year ending June
- Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2021 Quarterly Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 10, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To a
- Phibro Animal Health Corporation Reports First Quarter ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its first quarter ended September 30, 2021. Highlights for the three months ended September 30, 2021 (compared to the three months ended September 30, 2020) Net sales of $215 million, an increase of $20 million, or 10% Net income of $7 million, a decrease of $6 million, or 47% Diluted EPS of $0.16, a decrease of $0.14, or 47% Adjusted EBITDA of $22 million, a decrease of $2 million, or 8% Adjusted net income of $10 million, a decrease of $1 million, or 6% Adjusted diluted EPS of $0.25, a decrease of $0.02, or 7% The Company revised financial guidance for the fiscal year ending June 30, 202
- Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2021 Quarterly Financial ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Tuesday, November 2, 2021, after the market closes. Phibro management will host a conference call and webcast on Wednesday, November 3, 2021, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To acce
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial GuidancePhibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its fourth quarter and fiscal year ended June 30, 2021, and provided financial guidance for the year ending June 30, 2022. Highlights for the three months ended June 30, 2021 (compared to the three months ended June 30, 2020) Net sales of $220 million, an increase of $34 million, or 19% Net income of $17 million, an increase of $12 million, or 203% Diluted EPS of $0.42, an increase of $0.28, or 200% Adjusted EBITDA of $27 million, an increase of $3 million, or 13% Adjusted Net Income of $13 million, an increase of $6 million, or 89% Adjusted diluted EPS of $0.32, an increase of $0.15, or 88%
- Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2021 ResultsPhibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2021 financial results on Wednesday, August 25, 2021, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 26, 2021, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (833) 968-1955 in the U.S. and Canada, or +1 (647) 689-6656 for international callers. Provide the conference ID 4134939. A replay of the webcast will be available approximately two hours after the conclusion of th